Tag: CCH

November 17, 2016

BioSpecifics Technologies Reports Positive Data from Phase 2b Study of CCH

BioSpecifics Technologies today reports positive results from a Phase 2b study of CCH, which treats cellulite or edematous fibrosclerotic panniculopathy.
February 17, 2016

Endo Starts Phase 2B Clinical Trial of Collagenase Clostridium Histolyticum in Cellulite

Endo International plc (NASDAQ: ENDP, TSX: ENL) has started its Phase 2b study of collagenase clostridium histolyticum for the treatment...